|
1
|
Goker A, Guvenal T, Yanikkerem E, Turhan A
and Koyuncu FM: Quality of life in women with gynecologic cancer in
Turkey. Asian Pac J Cancer Prev. 12:3121–3128. 2011.PubMed/NCBI
|
|
2
|
Zhang B, Cai FF and Zhong XY: An overview
of biomarkers for the ovarian cancer diagnosis. Eur J Obstet
Gynecol Reprod Biol. 158:119–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matsuda A and Katanoda K: Five-year
relative survival rate of ovarian cancer in the USA, Europe and
Japan. Jpn J Clin Oncol. 44:1962014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fukuda M: Regulation of secretory vesicle
traffic by Rab small GTPases. Cell Mol Life Sci. 65:2801–2813.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grosshans BL, Ortiz D and Novick P: Rabs
and their effectors: Achieving specificity in membrane traffic.
Proc Natl Acad Sci USA. 103:11821–11827. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pfeffer SR: Structural clues to Rab GTPase
functional diversity. J Biol Chem. 280:15485–15488. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Paul P, Simm S, Mirus O, Scharf KD,
Fragkostefanakis S and Schleiff E: The complexity of vesicle
transport factors in plants examined by orthology search. PLoS ONE.
9:e977452014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pfeffer S: A model for Rab GTPase
localization. Biochem Soc Trans. 33:627–630. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wright PK: Targeting vesicle trafficking:
An important approach to cancer chemotherapy. Recent Pat Anticancer
Drug Discov. 3:137–147. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hendrix A, Braems G, Bracke M, Seabra M,
Gahl W, De Wever O and Westbroek W: The secretory small GTPase
Rab27B as a marker for breast cancer progression. Oncotarget.
1:304–308. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Malpica A, Deavers MT, Lu K, Bodurka DC,
Atkinson EN, Gershenson DM and Silva EG: Grading ovarian serous
carcinoma using a two-tier system. Am J Surg Pathol. 28:496–504.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feng J, Xu L, Ni S, Gu J, Zhu H, Wang H,
Zhang S, Zhang W and Huang J: Involvement of FoxQ1 in NSCLC through
regulating EMT and increasing chemosensitivity. Oncotarget.
5:9689–9702. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang J, Zhang J, Li H, Lu Z, Shan W,
Mercado-Uribe I and Liu J: VCAM1 expression correlated with
tumorigenesis and poor prognosis in high grade serous ovarian
cancer. Am J Transl Res. 5:336–346. 2013.PubMed/NCBI
|
|
15
|
Feng J, Zhang X, Zhu H, Wang X, Ni S and
Huang J: High expression of FoxP1 is associated with improved
survival in patients with non-small cell lung cancer. Am J Clin
Pathol. 138:230–235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong W, Mou Q, Chen J, Cui J, Li W and
Xiao W: Differential expression of Rab27A/B correlates with
clinical outcome in hepatocellular carcinoma. World J
Gastroenterol. 18:1806–1813. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Westbroek W, Tuchman M, Tinloy B, De Wever
O, Vilboux T, Hertz JM, Hasle H, Heilmann C, Helip-Wooley A, Kleta
R and Gahl WA: A novel missense mutation (G43S) in the switch I
region of Rab27A causing Griscelli Syndrome. Mol Genet Metab.
94:248–254. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Westbroek W, Lambert J, De Schepper S,
Kleta R, Van Den Bossche K, Seabra MC, Huizing M, Mommaas M and
Naeyaert JM: Rab27b is up-regulated in human Griscelli syndrome
type II melanocytes and linked to the actin cytoskeleton via exon
F-myosin Va transcripts. Pigment Cell Res. 17:498–505. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jordens I, Westbroek W, Marsman M, Rocha
N, Mommaas M, Huizing M, Lambert J, Naeyaert JM and Neefjes J: Rab7
and Rab27a control two motor protein activities involved in
melanosomal transport. Pigment Cell Res. 19:412–423. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dai Y, Liu Y, Huang D, Yu C, Cai G, Pi L,
Ren C, Chen GZ, Tian Y and Zhang X: Increased expression of Rab
coupling protein in squamous cell carcinoma of the head and neck
and its clinical significance. Oncol Lett. 3:1231–1236.
2012.PubMed/NCBI
|
|
21
|
Cheng KW, Lahad JP, Kuo WL, Lapuk A,
Yamada K, Auersperg N, Liu J, Smith-McCune K, Lu KH, Fishman D, et
al: The RAB25 small GTPase determines aggressiveness of ovarian and
breast cancers. Nat Med. 10:1251–1256. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng KW, Lahad JP, Gray JW and Mills GB:
Emerging role of RAB GTPases in cancer and human disease. Cancer
Res. 65:2516–2519. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan Y, Xin XY, Chen BL and Ma X: Knockdown
of RAB25 expression by RNAi inhibits growth of human epithelial
ovarian cancer cells in vitro and in vivo. Pathology.
38:561–567. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Tao X, Jia L, Cheng KW, Lu Y, Yu Y
and Feng Y: Knockdown of RAB25 promotes autophagy and inhibits cell
growth in ovarian cancer cells. Mol Med Rep. 6:1006–1012.
2012.PubMed/NCBI
|
|
25
|
Subramani D and Alahari SK:
Integrin-mediated function of Rab GTPases in cancer progression.
Mol Cancer. 9:3122010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dong WW, Mou Q, Chen J, Cui JT, Li WM and
Xiao WH: Differential expression of Rab27A/B correlates with
clinical outcome in hepatocellular carcinoma. World J
Gastroenterol. 18:1806–1813. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang JX, Huang XX, Cai MB, Tong ZT, Chen
JW, Qian D, Liao YJ, Deng HX, Liao DZ, Huang MY, et al:
Overexpression of the secretory small GTPase Rab27B in human breast
cancer correlates closely with lymph node metastasis and predicts
poor prognosis. J Transl Med. 10:2422012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hendrix A, Westbroek W, Bracke M and De
Wever O: An ex(o)citing machinery for invasive tumor growth. Cancer
Res. 70:9533–9537. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ostenfeld MS, Jeppesen DK, Laurberg JR,
Boysen AT, Bramsen JB, Primdal-Bengtson B, Hendrix A, Lamy P,
Dagnaes-Hansen F, Rasmussen MH, et al: Cellular disposal of miR23b
by RAB27-dependent exosome release is linked to acquisition of
metastatic properties. Cancer Res. 74:5758–5771. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang W, Ni Q, Wang H, Zhang S and Zhu H:
Prognostic value of Rab27B nuclear expression in gastrointestinal
stromal tumors. Dis Markers. 2014:9421812014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu YZ, Xi QH, Ge WL and Zhang XQ:
Identification of serum microRNA-21 as a biomarker for early
detection and prognosis in human epithelial ovarian cancer. Asian
Pac J Cancer Prev. 14:1057–1060. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lambert HE, Gregory WM, Nelstrop AE and
Rustin GJ: Long-term survival in 463 women treated with platinum
analogs for advanced epithelial carcinoma of the ovary: Life
expectancy compared to women of an age-matched normal population.
Int J Gynecol Cancer. 14:772–778. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
McGuire WP 3rd: Current status of taxane
and platinum-based chemotherapy in ovarian cancer. J Clin Oncol.
21:S133–S135. 2003. View Article : Google Scholar
|
